Profile
SNPX VRTX REGN VRNA ARGX ALNY
Company Name Synaptogenix, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $10.91M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Alan J. Tuchman MBA(FAAN) Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SNPX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
SNPX VRTX REGN VRNA ARGX ALNY
Last Close $7.85 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $7.85 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $2.01 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High 0 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 290.55 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SNPX VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 263.43 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 178.36 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 126.22 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 225.73 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SNPX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -24.92 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) -0.77 % - 8.22 % - - -
Growth
SNPX VRTX REGN VRNA ARGX ALNY
Asset Growth -43 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 12.08 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -53.58 % 9.09 % -131.37 % 24.59 %
Net Income Growth -111.45 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 83.58 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 96.49 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 77.66 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 18.08 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 5.59 % - -143.33 % -107.98 %
Operating 3 Year CFG 90.91 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 98.33 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 87.76 % -100 % 40.15 % 97.08 %
EPS Growth 62.82 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 62.82 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -89.99 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -96.72 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -98.42 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -95.07 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth 56038528.74 % - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth - 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 5.64 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SNPX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 60.1 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -145.14 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -225.56 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -46.68 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.17 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 329.09 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -86045.35 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 92.91 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 0.05 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.01 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.01 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 56.69 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -54418.54 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -2.13 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -3.92 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -3.92 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
SNPX VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -10.99 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
SNPX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.01B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.02B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
SNPX VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $-950.92B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24
AARD Aardvark Therapeutics, Inc. Common Stock 12.3411
ABCL AbCellera Biologics Inc. 3.0687
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.04
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.45
ABPWW 0.0133
ABSI Absci Corporation 2.505
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.65
ABVX Abivax SA American Depositary Shares 123.45
ACAD ACADIA Pharmaceuticals Inc. 22.242
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.876
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.21
ACIU AC Immune SA 2.97
ETFs With Exposure to SNPX
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 218.35
IWC iShares Micro-Cap ETF 0.00008 166.94
DFAC Dimensional U.S. Core Equity 2 ETF 0 41.36
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.55
DFSU Dimensional US Sustainability Core 1 ETF 0 44.13
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000174594 16.69
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.56
VEMPX Vanguard Extended Market Index InstlPlus 0 408.54
Unlock